Market Closed -
Japan Exchange
02:00:00 2024-04-26 EDT
|
5-day change
|
1st Jan Change
|
4,852
JPY
|
-0.16%
|
|
-1.40%
|
-9.17%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,518,359
|
9,045,924
|
6,141,311
|
5,540,406
|
8,789,053
|
7,983,063
|
-
|
-
|
Enterprise Value (EV)
1 |
5,185,301
|
8,667,304
|
5,669,311
|
5,051,408
|
8,050,071
|
7,102,495
|
6,980,320
|
6,833,877
|
P/E ratio
|
35
x
|
42.1
x
|
20.3
x
|
14.8
x
|
27
x
|
23.2
x
|
21.7
x
|
20.4
x
|
Yield
|
1.39%
|
1%
|
2.03%
|
2.32%
|
1.5%
|
1.74%
|
1.84%
|
1.89%
|
Capitalization / Revenue
|
8.04
x
|
11.5
x
|
6.14
x
|
4.4
x
|
7.91
x
|
7.31
x
|
7.04
x
|
6.78
x
|
EV / Revenue
|
7.56
x
|
11
x
|
5.67
x
|
4.01
x
|
7.24
x
|
6.51
x
|
6.15
x
|
5.8
x
|
EV / EBITDA
|
22.5
x
|
26.1
x
|
12.3
x
|
8.93
x
|
17.1
x
|
14.4
x
|
13.6
x
|
12.9
x
|
EV / FCF
|
41.5
x
|
81.2
x
|
35.3
x
|
27.7
x
|
21.6
x
|
20.9
x
|
21.7
x
|
19.9
x
|
FCF Yield
|
2.41%
|
1.23%
|
2.83%
|
3.61%
|
4.63%
|
4.79%
|
4.61%
|
5.03%
|
Price to Book
|
6.46
x
|
9.23
x
|
5.17
x
|
3.89
x
|
5.41
x
|
4.42
x
|
3.76
x
|
3.34
x
|
Nbr of stocks (in thousands)
|
1,642,369
|
1,643,817
|
1,644,260
|
1,645,014
|
1,645,274
|
1,645,314
|
-
|
-
|
Reference price
2 |
3,360
|
5,503
|
3,735
|
3,368
|
5,342
|
4,852
|
4,852
|
4,852
|
Announcement Date
|
20-01-30
|
21-02-04
|
22-02-03
|
23-02-02
|
24-02-01
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
686,184
|
786,900
|
999,800
|
1,259,946
|
1,111,367
|
1,091,346
|
1,134,578
|
1,177,952
|
EBITDA
1 |
230,967
|
332,600
|
459,100
|
565,376
|
470,914
|
492,349
|
514,577
|
528,112
|
EBIT
1 |
210,597
|
301,200
|
421,900
|
533,309
|
439,174
|
467,911
|
499,004
|
529,915
|
Operating Margin
|
30.69%
|
38.28%
|
42.2%
|
42.33%
|
39.52%
|
42.87%
|
43.98%
|
44.99%
|
Earnings before Tax (EBT)
1 |
207,893
|
298,200
|
419,400
|
531,166
|
443,821
|
471,033
|
503,963
|
535,490
|
Net income
1 |
157,560
|
214,700
|
303,000
|
374,429
|
325,472
|
345,245
|
368,453
|
392,430
|
Net margin
|
22.96%
|
27.28%
|
30.31%
|
29.72%
|
29.29%
|
31.63%
|
32.47%
|
33.31%
|
EPS
2 |
95.95
|
130.7
|
184.3
|
227.6
|
197.8
|
209.5
|
223.5
|
238.1
|
Free Cash Flow
1 |
124,900
|
106,723
|
160,699
|
182,312
|
372,635
|
340,431
|
321,522
|
343,677
|
FCF margin
|
18.2%
|
13.56%
|
16.07%
|
14.47%
|
33.53%
|
31.19%
|
28.34%
|
29.18%
|
FCF Conversion (EBITDA)
|
54.08%
|
32.09%
|
35%
|
32.25%
|
79.13%
|
69.14%
|
62.48%
|
65.08%
|
FCF Conversion (Net income)
|
79.27%
|
49.71%
|
53.04%
|
48.69%
|
114.49%
|
98.61%
|
87.26%
|
87.58%
|
Dividend per Share
2 |
46.67
|
55.00
|
76.00
|
78.00
|
80.00
|
84.46
|
89.31
|
91.50
|
Announcement Date
|
20-01-30
|
21-02-04
|
22-02-03
|
23-02-02
|
24-02-01
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 S1
|
---|
Net sales
1 |
365,899
|
368,120
|
390,229
|
287,264
|
322,300
|
360,554
|
235,600
|
596,200
|
225,300
|
438,446
|
312,240
|
267,417
|
579,657
|
257,898
|
273,812
|
236,900
|
277,386
|
521,000
|
275,285
|
295,945
|
259,000
|
545,000
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
107,900
|
128,800
|
-
|
121,000
|
120,300
|
-
|
-
|
EBIT
1 |
115,545
|
140,629
|
160,679
|
122,156
|
139,100
|
187,007
|
99,900
|
286,900
|
96,900
|
149,509
|
98,296
|
112,614
|
210,910
|
106,688
|
121,576
|
99,900
|
120,281
|
215,200
|
119,205
|
126,325
|
115,100
|
238,200
|
Operating Margin
|
31.58%
|
38.2%
|
41.18%
|
42.52%
|
43.16%
|
51.87%
|
42.4%
|
48.12%
|
43.01%
|
34.1%
|
31.48%
|
42.11%
|
36.39%
|
41.37%
|
44.4%
|
42.17%
|
43.36%
|
41.31%
|
43.3%
|
42.69%
|
44.44%
|
43.71%
|
Earnings before Tax (EBT)
1 |
114,113
|
139,565
|
161,256
|
119,689
|
138,400
|
186,206
|
100,700
|
286,900
|
95,000
|
149,266
|
99,662
|
113,994
|
213,656
|
107,475
|
122,690
|
99,900
|
126,400
|
216,700
|
130,600
|
129,100
|
115,400
|
238,700
|
Net income
1 |
88,306
|
102,293
|
118,137
|
86,017
|
98,800
|
131,775
|
72,400
|
204,200
|
67,800
|
102,429
|
73,500
|
83,193
|
156,693
|
77,573
|
91,206
|
74,400
|
89,295
|
157,450
|
89,681
|
91,632
|
85,900
|
175,700
|
Net margin
|
24.13%
|
27.79%
|
30.27%
|
29.94%
|
30.65%
|
36.55%
|
30.73%
|
34.25%
|
30.09%
|
23.36%
|
23.54%
|
31.11%
|
27.03%
|
30.08%
|
33.31%
|
31.41%
|
32.19%
|
30.22%
|
32.58%
|
30.96%
|
33.17%
|
32.24%
|
EPS
2 |
-
|
62.26
|
71.86
|
52.31
|
60.11
|
80.14
|
44.00
|
124.1
|
41.21
|
62.29
|
44.68
|
50.57
|
95.25
|
47.15
|
55.43
|
45.22
|
52.88
|
96.50
|
54.37
|
59.93
|
52.20
|
106.8
|
Dividend per Share
|
-
|
25.00
|
30.00
|
-
|
-
|
-
|
-
|
38.00
|
-
|
-
|
-
|
-
|
40.00
|
-
|
40.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-01-30
|
20-07-27
|
21-07-26
|
21-10-22
|
22-02-03
|
22-04-25
|
22-07-21
|
22-07-21
|
22-10-24
|
23-02-02
|
23-04-27
|
23-07-27
|
23-07-27
|
23-10-24
|
24-02-01
|
24-04-24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
333,058
|
378,620
|
472,000
|
488,998
|
738,982
|
880,569
|
1,002,743
|
1,149,187
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
124,900
|
106,723
|
160,699
|
182,312
|
372,635
|
340,431
|
321,522
|
343,677
|
ROE (net income / shareholders' equity)
|
19.6%
|
23.4%
|
28%
|
28.7%
|
21.3%
|
20.1%
|
18.6%
|
17.4%
|
ROA (Net income/ Total Assets)
|
15.9%
|
26%
|
30.2%
|
31.2%
|
23.3%
|
16.8%
|
15.2%
|
13.8%
|
Assets
1 |
989,232
|
826,007
|
1,002,158
|
1,201,341
|
1,394,192
|
2,050,962
|
2,417,668
|
2,847,826
|
Book Value Per Share
2 |
520.0
|
596.0
|
723.0
|
866.0
|
988.0
|
1,099
|
1,289
|
1,455
|
Cash Flow per Share
2 |
108.0
|
149.0
|
203.0
|
247.0
|
217.0
|
261.0
|
237.0
|
246.0
|
Capex
1 |
53,009
|
57,040
|
65,969
|
61,800
|
71,948
|
66,072
|
67,548
|
68,635
|
Capex / Sales
|
7.73%
|
7.25%
|
6.6%
|
4.9%
|
6.47%
|
6.05%
|
5.95%
|
5.83%
|
Announcement Date
|
20-01-30
|
21-02-04
|
22-02-03
|
23-02-02
|
24-02-01
|
-
|
-
|
-
|
Last Close Price
4,852
JPY Average target price
6,044
JPY Spread / Average Target +24.56% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.17% | 50.71B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|